Author

A. Jarjoui

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Assay:ChIP-seq· 1 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Quteineh· 1 shared A. Rokach· 1 shared A. Tzankov· 1 shared B. Glaser· 1 shared C. Chen-Shuali· 1 shared C. Zinner· 1 shared D. Bohm· 1 shared D. Kochan· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Quteineh

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Epigenetic liquid biopsies reveal elevated vascular endothelial cell turnover and erythropoiesis in asymptomatic COVID-19 patients

R. Ben Ami, N. Loyfer, E. Cohn, G. Fialkoff, I. Sharkia, N. Bogot, D. Kochan, G. Kalak, A. Jarjoui, C. Chen-Shuali, H. Azulai, H. Barhoum, N. Arish, M. M. Greenberger, D. Velleman, , Y. Dor

This study uses epigenetic liquid biopsies to show that asymptomatic COVID-19 patients have elevated vascular endothelial cell and erythroblast turnover, indicating sub-clinical vascular and erythrocyte damage.

bioRxiv · Jul 28, 2023 · PreprintMicrobiology

COVID-19 patients have increased levels of membrane-associated and soluble CD48

H. Pahima, I. Zaffran, E. Ben-Chetrit, A. Jarjoui, P. Gaur, M. L. Manca, D. Reichmann, E. Orenbuch-Harroch, I. Puxeddu, C. Zinner, A. Tzankov, F. Levi-Schaffer

The paper finds increased levels of membrane-bound and soluble CD48 in COVID-19 patients through various assays, suggesting a potential therapeutic target.

bioRxiv · Mar 18, 2022 · PreprintImmunology